Inventor · disambiguated record
Lynda Chin
Also filed as: CHIN LYNDA
9 granted patents·20 pending applications·90 citations·filing 2000–2024
86Inventor score
Files withDANA FARBER CANCER INST INC9DEPINHO RONALD A8Apricity Health LLC5CHIN LYNDA3APRICITY HEALTH INC1
Top patents by PatentIndex Score
29 records- 0193US8211634B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancerDEPINHO RONALD A·Filed 2007·Granted Jul 3, 2012·37 cites·16 claims
- 0291US6639121B1Inducible cancer model to study the molecular basis of host tumor cell interactions in vivoDANA FARBER CANCER INST INC·Filed 2000·Granted Oct 28, 2003·27 cites·47 claims
- 0390US8168602B2Compositions, kits and methods for identification, assessment, prevention and therapy of cancerDEPINHO RONALD A·Filed 2006·Granted May 1, 2012·15 cites·7 claims
- 0486US9309564B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancerDEPINHO RONALD A·Filed 2012·Granted Apr 12, 2016·5 cites·10 claims
- 0579US2024395375A1System and method for digital therapeutics implementing a digital deep layer patient profileAPRICITY HEALTH INC·Filed 2024·Application pending·0 cites
- 0673US8999633B2Compositions, kits, and methods for identification, assessment, prevention and treatment of pancreatic adenocarcinoma in humansCHIN LYNDA·Filed 2005·Granted Apr 7, 2015·3 cites·3 claims
- 0770US9458510B2Signatures and determinants associated with prostate cancer progression and methods of use thereofDEPINHO RONALD A·Filed 2012·Granted Oct 4, 2016·2 cites·12 claims
- 0868US2022359050A1System and method for digital therapeutics implementing a digital deep layer patient profileApricity Health LLC·Filed 2021·Application pending·0 cites
- 0962US11923051B2System and method for creating digital therapeutics directed to patient care specific to a diseaseApricity Health LLC·Filed 2019·Granted Mar 5, 2024·0 cites·30 claims
- 1061US2020232988A1Signatures and determinants associated with prostate cancer progression and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1160US2021057051A1System Architecture for Digital Therapeutics with Drug Therapy for Precision and Personalized Care PathwayApricity Health LLC·Filed 2019·Application pending·0 cites
- 1260US2011262464A1Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Cancer Using GOLPH3DANAFARBER CANCER INST INC·Filed 2009·Application pending·0 cites
- 1360US2021057106A1System and Method for Digital Therapeutics Implementing a Digital Deep Layer Patient ProfileApricity Health LLC·Filed 2019·Application pending·0 cites
- 1459US2004043437A1Inducible cancer model to study the molecular basis of host tumor cell interactions in vivoFiled 2003·Application pending·0 cites
- 1559US2011182881A1Signature and determinants associated with metastasis and methods of use thereofDANA FARBER CANCER INST INC·Filed 2009·Application pending·0 cites
- 1658US2011265197A1Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use ThereofDANA FARBER CANCER INST INC·Filed 2009·Application pending·0 cites
- 1758US2007107076A1Inducible cancer model to study the molecular basis of host tumor cell interactions in vivoDEPINHO RONALD A·Filed 2006·Application pending·0 cites
- 1857US2021057056A1System and Method for Developing Artificial Intelligent Digital Therapeutics with Drug Therapy for Precision and Personalized Care PathwayApricity Health LLC·Filed 2019·Application pending·0 cites
- 1955US7371515B2Identifying and characterizing genesDANA FARBER CANCER INST INC·Filed 2002·Granted May 13, 2008·1 cites·7 claims
- 2051US2016363596A1Signatures and determinants associated with prostate cancer progression and methods of use thereofDEPINHO RONALD A·Filed 2016·Application pending·0 cites
- 2151US2010298158A1Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of CancerDANA FARBER CANCER INST INC·Filed 2008·Application pending·0 cites
- 2250US2014235479A1Signatures and pcdeterminants associated with prostate cancer and methods of use thereofDEPINHO RONALD A·Filed 2014·Application pending·0 cites
- 2350US2014011748A1Methods Of Predicting Response To JNK Inhibitor TherapyCHIN LYNDA·Filed 2012·Application pending·0 cites
- 2445US2011030074A1Compositions and methods for cancer gene discoveryDANA FARBER CANCER INST INC·Filed 2008·Application pending·0 cites
- 2545US2017299594A1Signatures and pcdeterminants associated with prostate cancer and methods of use thereofDEPINHO RONALD A·Filed 2016·Application pending·0 cites
- 2643US7595158B2Bcl2L12 polypeptide activators and inhibitorsDANA FARBER CANCER INST INC·Filed 2005·Granted Sep 29, 2009·0 cites·20 claims
- 2740US2012004119A1Gene expression markers of oncolytic virus sensitivityLENBURG MARC·Filed 2011·Application pending·0 cites
- 2837US2013040853A1Context Specific Genetic Screen Platform to Aid in Gene Discovery and Target ValidationDANA FARBER CANCER INST INC·Filed 2011·Application pending·0 cites
- 2934US2014302042A1Methods of predicting prognosis in cancerCHIN LYNDA·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →